Celcuity, Inc. (CELC) – What Are Researchers Saying About This Stock?

Celcuity, Inc. (NASDAQ:CELC) has been given a consensus rating of “Moderate Buy” by the sixteen brokerages that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $152.57.

CELC has been the subject of several research reports. HC Wainwright reiterated a “buy” rating and issued a $155.00 target price on shares of Celcuity in a report on Friday, August 14th. Craig Hallum reissued a “buy” rating and set a $178.00 price target on shares of Celcuity in a research report on Wednesday, July 15th. Weiss Ratings restated a “sell (d-)” rating on shares of Celcuity in a research note on Tuesday, September 1st. JPMorgan Chase & Co. started coverage on Celcuity in a research note on Thursday, September 17th. They set an “overweight” rating and a $157.00 price target on the stock. Finally, Stifel Nicolaus decreased their price objective on Celcuity from $175.00 to $150.00 and set a “buy” rating for the company in a report on Friday, August 14th.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Integrity Alliance LLC. raised its position in shares of Celcuity by 2.2% in the 3rd quarter. Integrity Alliance LLC. now owns 11,868 shares of the company’s stock worth $944,000 after acquiring an additional 250 shares in the last quarter. Profund Advisors LLC lifted its stake in shares of Celcuity by 14.2% during the 3rd quarter. Profund Advisors LLC now owns 18,292 shares of the company’s stock worth $1,455,000 after purchasing an additional 2,280 shares during the last quarter. State of Wyoming purchased a new stake in shares of Celcuity during the 3rd quarter worth $251,000. China Universal Asset Management Co. Ltd. bought a new stake in Celcuity during the third quarter valued at about $105,000. Finally, Sterling Capital Management LLC boosted its position in Celcuity by 840.7% during the third quarter. Sterling Capital Management LLC now owns 1,270 shares of the company’s stock valued at $101,000 after purchasing an additional 1,135 shares in the last quarter. Hedge funds and other institutional investors own 63.33% of the company’s stock.

Celcuity Stock Performance

Shares of NASDAQ:CELC opened at $69.13 on Tuesday. The firm’s 50 day simple moving average is $77.67 and its 200-day simple moving average is $100.37. The company has a debt-to-equity ratio of 6.04, a quick ratio of 8.93 and a current ratio of 8.93. Celcuity has a one year low of $53.54 and a one year high of $151.02. The firm has a market cap of $3.38 billion, a PE ratio of -16.08 and a beta of 0.10.

Celcuity (NASDAQ:CELC) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($1.44) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.16) by ($0.28). As a group, equities analysts predict that Celcuity will post -4.98 EPS for the current year.

About Celcuity

Celcuity, Inc is a clinical-stage biotechnology company developing functional diagnostic tests designed to help identify cancer treatments that may be most effective for individual patients. Its technology analyzes living tumor cells taken from patients to measure how signaling pathways respond to different therapies, with the goal of supporting more personalized treatment decisions.

The company’s CELsignia platform is designed to assess the activity of cancer-related signaling pathways in patient-derived cells.